Data available from research groups in Sweden. See available data for all data types
Highlights of recent openly shared data and data re-use. See all highlights
Host factor interaction between human G3BP proteins and SARS-CoV-2 N-protein could represent an antiviral target
Kruse and Benz et al. describe a scalable method of investigating virus-host interactions that can be used as a means of identifying potential targets for novel antiviral drugs. All data from the study have been shared publicly.
Drug repurposing identifies Fostamatinib as a drug with potentially high efficacy in COVID-19 treatment
Recent study finds that drug repurposing can offer an average of an 11-fold increase in disease coverage and demonstrates its value for COVID-19. All data and code that support the findings have been made publicly available.
The COVID Human Genetic Efforts consortium published a study on genetic factors underlying greater susceptibility to the severe COVID-19 in men. Relevant RNA-seq data were shared in Gene Expression Omnibus (GEO).
Sample Collection Database
Registry of Swedish biobanks and sample collections for COVID-19 research. About the database
Overview of ongoing research projects, publications, and funding opportunities in Sweden.
Pages with recent data and visualizations on SARS-CoV-2 and COVID-19 tests carried out at various research facilities.
About this portal
The Swedish COVID-19 Data Portal provides information, guidelines, tools and services to support researchers to utilise Swedish and European infrastructures for data sharing. The portal is a national node of the European COVID-19 Data Portal. The portal is operated by the SciLifeLab Data Centre and partners. Suggestions, corrections, and other comments are most welcome.